Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Celestit Pharma ApS
APS
Bankrupt
CVR 41971541
Høbjergvej 29B
Manufacture of pharmaceutical preparations · NACE 2120
Est. 2020
— employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue
—
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit
—
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
Key figures
Annual report
Revenue
—
—
EBITDA
—
—
Net profit
—
—
Total assets
—
—
Equity
—
—
Employees
—
—
Company information
Legal name
Celestit Pharma ApS
CVR number
41971541
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
23. december 2020
Share capital
DKK 40.000
Employees
—
VAT registered
No
Audit selected
No
Last report
—
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Company purpose
Selskabets formål er at udvikle farmaceutiske produkter samt al virksomhed som efter direktionens skøn er beslægtet hermed
Contact
Address
Høbjergvej 29B
Recent events
1 entries
Event
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of pharmaceutical preparations
Companies in Gribskov
All Denmark companies
Revenue
DKK millions
EBITDA
DKK millions
Income statement
DKK thousands
Item
Revenue
Staff expenses
EBITDA
Depreciation & amort.
EBIT
Net financials
Profit before tax
Tax
Net profit
Balance sheet
DKK thousands
Item
Total assets
Equity
Long-term debt
Short-term debt
Total debt
Financial ratios
5-year trend
EBITDA margin
%
This company
15.8%
Market median
-NaN% vs market
Equity ratio
%
This company
38.2%
Market median
-NaN% vs market
Return on equity
%
This company
18.4%
Market median
-NaN% vs market
Net profit margin
%
This company
8.1%
Market median
-NaN% vs market
Asset turnover
×
This company
1.12×
Market median
-NaN% vs market
Debt / equity
×
This company
0.62×
Market median
-NaN% vs market
Annual reports & filings
Management
Actively employed in the business
Name
Role
Member since
Former (1)
JN
John Nikolaj Hvarre Christensen
Chief Executive Officer
Chief Executive Officer
2020 – 2022
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Nadavia Holding ApS
Company
50–66.65%
50–66.65%
2020
LOUTIANA HOLDING ApS
Company
15–19.99%
15–19.99%
2020
Mikael Gustav Wedell-Wedellsborg
Individual
10–14.99%
10–14.99%
2020
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Nadavia Holding ApS
Celestit Pharma ApS
(this company)
Board network connections
Board members of Celestit Pharma ApS also hold positions in
0
other companies.
Person
Role here
Other companies
John Nikolaj Hvarre Christensen
Chief Executive Officer
0 companies